|
|
|
Insider
Information: |
Walsh Matthew M |
Relationship: |
Chief Financial Officer |
City: |
Hampton |
State: |
NH |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
379,514 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$10,701,342 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
379,514 |
|
|
Total
Value |
$10,701,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
7.9%
|
25.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Catalent, Inc. |
CTLT |
EVP & Chief Financial ... |
2017-08-24 |
103,703 |
|
0 |
Premium* |
|
Multi Color Corp |
LABL |
Director |
2016-10-03 |
1,854 |
2015-10-01 |
0 |
Premium* |
|
Allergan plc |
AGN |
EVP, Chief Financial O... |
2020-05-08 |
0 |
2018-02-20 |
0 |
Premium* |
|
Certara, Inc. |
CERT |
|
2024-05-21 |
185,631 |
|
0 |
Premium* |
|
Organon & Co. |
OGN |
Chief Financial Officer |
2024-05-04 |
88,326 |
2021-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTLT |
Catalent, Inc. |
See RemarksOfficer |
|
2014-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,742 |
|
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-02-13 |
4 |
S |
$28.11 |
$89,952 |
D/D |
(3,200) |
95,542 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-03-27 |
4 |
D |
$30.10 |
$332,274 |
D/D |
(11,039) |
84,503 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-04-06 |
4 |
OE |
$10.71 |
$1,092,881 |
D/D |
102,043 |
184,546 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-04-06 |
4 |
D |
$30.43 |
$2,068,844 |
D/D |
(67,987) |
116,559 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-04-06 |
4 |
S |
$30.43 |
$1,047,979 |
D/D |
(34,439) |
84,120 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-07-27 |
4 |
AS |
$31.18 |
$847,223 |
D/D |
(27,172) |
84,120 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-07-27 |
4 |
D |
$30.50 |
$1,755,123 |
D/D |
(57,545) |
99,740 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-07-27 |
4 |
OE |
$10.71 |
$974,229 |
D/D |
84,717 |
130,880 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2015-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,068 |
88,188 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2016-05-27 |
4 |
S |
$28.85 |
$611,533 |
D/D |
(21,197) |
88,188 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2016-05-27 |
4 |
OE |
$14.86 |
$1,398,010 |
D/D |
89,124 |
107,312 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2016-05-27 |
4 |
D |
$28.85 |
$1,959,694 |
D/D |
(67,927) |
91,712 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2016-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,524 |
93,712 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2017-06-08 |
4 |
OE |
$10.71 |
$884,064 |
D/D |
74,651 |
168,363 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2017-06-08 |
4 |
D |
$37.01 |
$1,735,814 |
D/D |
(46,903) |
121,460 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2017-06-08 |
4 |
AS |
$0.00 |
$0 |
D/D |
(24,989) |
96,471 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2017-06-09 |
4 |
AS |
$0.00 |
$0 |
D/D |
(2,759) |
93,712 |
0 |
- |
|
CTLT |
Catalent, Inc. |
See Remarks |
|
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,275 |
98,987 |
0 |
- |
|
AGN |
Allergan plc |
EVP, Chief Financial Officer |
|
2018-02-20 |
4 |
A |
$160.59 |
$3,599,785 |
D/D |
22,416 |
22,416 |
0 |
- |
|
AGN |
Allergan plc |
EVP, Chief Financial Officer |
|
2018-02-21 |
4 |
B |
$160.94 |
$321,880 |
D/D |
2,000 |
24,416 |
2.74 |
- |
|
AGN |
Allergan plc |
EVP, Chief Financial Officer |
|
2018-03-08 |
4 |
B |
$153.96 |
$153,960 |
D/D |
1,000 |
25,416 |
2.74 |
- |
|
AGN |
Allergan plc |
EVP, Chief Financial Officer |
|
2018-11-16 |
4 |
B |
$157.00 |
$157,000 |
D/D |
1,000 |
26,416 |
2.74 |
- |
|
AGN |
Allergan plc |
EVP, Chief Financial Officer |
|
2019-02-20 |
4 |
D |
$140.33 |
$313,638 |
D/D |
(2,235) |
24,181 |
0 |
- |
|
AGN |
Allergan plc |
EVP, Chief Financial Officer |
|
2020-03-02 |
4 |
A |
$193.84 |
$2,999,868 |
D/D |
15,476 |
39,657 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|